Model Number 1804350-28 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Angina (1710); Cardiac Arrest (1762); Respiratory Failure (2484); Thrombosis/Thrombus (4440)
|
Event Date 03/10/2023 |
Event Type
Death
|
Manufacturer Narrative
|
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
|
|
Event Description
|
It was reported that on (b)(6) 2022, a procedure was performed to treat lesions in the proximal and mid left anterior descending (lad) vessels.Two non-abbott stents were implanted in the first marginal and proximal to mid lad lesions.On (b)(6) 2023, restenosis was noted in the first marginal which was treated with a drug coated balloon.On (b)(6) 2023, restenosis was observed in the proximal to mid lad.The 3.5x28mm xience skypoint stent was implanted in the proximal to mid lad, overlapping the previously implanted stent for treatment.No abnormity was noted with the xience stent or flow after stent implantation.On (b)(6) 2023, the patient returned to the hospital.The patient was experiencing chest pain and was in a state of cardiopulmonary arrest (cpa).Imaging confirmed total occlusion from distal of the implanted xience stent.Thrombus aspiration was performed; however, did not aspirate much thrombus.Reperfusion was performed with balloon dilatation, but the patient did not recover.The following day the patient expired.No additional information was provided.
|
|
Event Description
|
Subsequent to the previously filed report, the following correction was made: prior to the restenosis noted on (b)(6) 2023, the order of events were as follows on (b)(6) 2022, a non-abbott stent was implanted in the stenosed lesion of the first marginal coronary artery.On (b)(6) 2022, a non-abbott stent was implanted in the proximal to mid left anterior descending (lad) coronary artery.
|
|
Manufacturer Narrative
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect(s) of thrombosis, angina and death are listed in the xience skypoint everolimus eluting coronary stent systems instructions for use as a known patient effect(s) of coronary stenting procedures.A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling; therefore, no product-related corrective action will be implemented in this case.B5: describe event or problem.
|
|
Search Alerts/Recalls
|
|